A Commitment to Excellence
Our History in Oncology
Dr. Hamdy A. Azim, MD
Chairman and Founder of Cairo Cure
Cairo Cure was founded in 1992 by Prof. Hamdy A. Azim,
a professor of clinical oncology at Cairo University, who is a
renowned expert in the field of oncology in the Middle East
region.
Cairo Cure was founded with the aim to develop it as a leading private oncology facility in Egypt and the Middle East. Dr. Azim had a vision of attracting the top talents in the field of medical and radiation oncology, to work together as a team to deliver a unique oncology service under the same roof.
Since the early 2000s, Cairo Cure is considered to be one of the biggest private oncology centers in the Middle East region. It has served as a strong platform to bring forward oncologists that evolve to become experts in the field, not only on the local but also at the international level.
Thanks to the high quality of medical care offered by Cairo Cure and its scientific leadership, Cairo Cure has participated in numerous international clinical trials that led to the approval of novel anticancer agents that are currently widely used in clinical practice. This allowed Cairo Cure patients to be offered novel agents well before their availability on the Egyptian market, and at no cost to the patient.
Cairo Cure was founded with the aim to develop it as a leading private oncology facility in Egypt and the Middle East. Dr. Azim had a vision of attracting the top talents in the field of medical and radiation oncology, to work together as a team to deliver a unique oncology service under the same roof.
Since the early 2000s, Cairo Cure is considered to be one of the biggest private oncology centers in the Middle East region. It has served as a strong platform to bring forward oncologists that evolve to become experts in the field, not only on the local but also at the international level.
Thanks to the high quality of medical care offered by Cairo Cure and its scientific leadership, Cairo Cure has participated in numerous international clinical trials that led to the approval of novel anticancer agents that are currently widely used in clinical practice. This allowed Cairo Cure patients to be offered novel agents well before their availability on the Egyptian market, and at no cost to the patient.
Milestones in Cancer Care
A Timeline of Cairo
Cure’s Evolution
Cure’s Evolution
1992
Founded
1999
First Expansion of the outpatient
oncology facility
oncology facility
2000
Establishing first oncology clinic
pharmacy in private practice in Egypt
pharmacy in private practice in Egypt
2003
Opening an in-patient
oncology facility at el
Shorouk Hospital
oncology facility at el
Shorouk Hospital
2002
Initiate partnership second opinion
program with the University of
Nebraska Medical center
program with the University of
Nebraska Medical center
2001
Second Expansion of the
outpatient oncology facility
outpatient oncology facility
2005
Third Expansion of the
outpatient oncology
outpatient oncology
2014
Certification and accreditation
by the European Society
for Medical Oncology (ESMO)
by the European Society
for Medical Oncology (ESMO)
2017
Become a certified member of the Breast
Centers network, an international network
of clinical centers dedicated to the diagnosis
and treatment of breast cancer
Centers network, an international network
of clinical centers dedicated to the diagnosis
and treatment of breast cancer
2024
Integration of a lab service at Cairo Cure
in collaboration with AlMaamal
Expansion of the in-patient services in
As-Salam Hospital
in collaboration with AlMaamal
Expansion of the in-patient services in
As-Salam Hospital